5'-メチルチオコフォーミシン合成:マラリア性アデノシンデアミナーゼの特定の阻害剤
Peter C Tyler1, Erika A Taylor, Richard F G Fröhlich
1Carbohydrate Chemistry Team, Industrial Research Ltd., Lower Hutt, New Zealand. p.tyler@irl.cri.nz
Journal of the American Chemical Society
|May 10, 2007
まとめ
新しい移行状態のアナログ阻害剤は,特にプラズモディアム・ファルシパラムのアデノシン・デアミナーゼ (PfADA) を標的とし,ヒト細胞に害を与えることなく,潜在的な抗マラリア治療を提供しています. これらの強力な阻害剤は,マラリア治療の有望性を示しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 酵素の動力学について
- 薬剤化学 薬剤化学について
背景:
- 酵素速度の加速は,移行状態の安定化に関連しています.
- トランジション状態のアナログ阻害剤は,酵素に強く結合する.
- アデノシンデアミナーゼ (ADA) は, purin代謝における重要な酵素である.
研究 の 目的:
- プラズモディアム・ファルシパラム (Plasmodium falciparum) ADA (PfADA) に対する特定のトランジション状態アナログ阻害剤の設計と合成.
- 新しい化合物のPfADAに対する抑制力を評価し,ヒトおよび牛のADAと比較する.
- 抗マラリア剤としてのPfADA固有の阻害剤の治療の可能性を探求する.
主な方法:
- 5'-メチルチオコフォーミシンと5'-メチルチオ-2'-デオキシコフォーミシンを移行状態のミミカとして合成.
- 酵素阻害アッセイは,PfADA,ヒト ADA (HsADA),牛 ADA (BtADA) の解離定数 (Kd) を決定する.
- 宿主酵素の抑制を評価することにより,寄生虫特異性の評価.
主要な成果:
- 合成されたアナログは,ピコモラー範囲 (430 と 790 pM) の解離定数を持つPfADAを強力に抑制しました.
- これらの化合物は,HsADAとBtADAに対する検出可能な阻害を示せず,高い特異性を示しました.
- PfADAのユニークな基板特異性は,寄生虫特異的抑制を達成するために利用されました.
結論:
- 5'-メチルチオコフォーミシンと5'-メチルチオ-2'-デオキシコフォーミシンは,プラズモジア・ファルシパラム (Plasmodium falciparum ADA) の強力で特異的な阻害剤である.
- これらの阻害剤は,寄生虫の purin salvage 経路を標的とした新しい抗マラリア薬の開発のための有望なリードを表しています.
- 寄生虫特異のADA阻害剤の開発は,ヒトのADAを阻害することに関連する毒性を回避する可能性がある.
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...